TARDBP and amyotrophic lateral sclerosis: 2–4 TDP-43 pathology defines a subgroup of patients with FTD with frontotemporal lobar degeneration (FTLD-TDP) and is also observed in 95% of patients with amyotrophic lateral sclerosis (ALS) and some patients with Alzheimer’s disease (AD).